jump to navigation

Cardiac output monitoring technology developer Cheetah Medical raises $20 million March 16, 2010

Posted by israelhealthcare in Cardiology.
Tags: , , , , , , ,
trackback

Noninvasive hemodynamic and cardiac output monitoring technology developer Cheetah Medical has raised $20 million in a second financing round. The investment round was led by Ascension Health Ventures (AHV) and also included Robert Bosch Venture Capital (RBVC), the investment arm of Bosch Group, MVM Life Science Partners and existing investors.

Cheetah Medical’s NICOM products provides a simple to use platform that enables physicians and nurses to quickly obtain accurate advanced hemodynamic parameters at the bedside, thereby aiding in differential diagnosis and selection and titration of the appropriate therapy to individualize patient care. Legacy approaches that rely on invasive, costly catheters have more limited use due to concerns about cost, maintenance requirements, invasiveness and potential complications.

“Because of its accuracy and non-invasiveness, Cheetah’s NICOM platform has the potential to significantly expand the hemodynamic monitoring market,” said Dr. Walter Lin, an Investment Manager with AHV. “The company validated technology can both improve outcomes and reduce the cost of care in what is generally a high acuity patient population.”

“By providing accurate, noninvasive, continuous hemodynamic information, NICOM can improve patient outcomes by helping clinicians optimize fluid and vasoactive drug management in areas such as critical care, anesthesia, emergency medicine and heart failure,” explain Yoav Avidor, CEO of Cheetah Medical.

Cheetah Medical’s NICOM noninvasive cardiac output and hemodynamic monitoring system uses the company’s proprietary BIOREACTANCE technology to deliver continuous, accurate, noninvasive cardiac output and other vital hemodynamic monitoring parameters. The system is US FDA cleared and CE Marked, and since its commercial launch in 2008 has been adopted by a growing number of clinicians worldwide.

Cheetah Medical headquarters is located in Tel-Aviv, Israel and its United States headquarters is located in Portland, Oregon.

Sponsored Links – Mobile Health Systems | Compression Therapy Devices

Advertisements

Comments»

1. Blood Pressure Monitors What is the relation of hypertension and risk for decrease cardiac output? - March 24, 2010

[…] Cardiac output monitoring technology developer Cheetah Medical raises $20 million « Israel Hea… […]


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: